Respiratory failure & ventilation

Factors influencing the transition phase in acute respiratory distress syndrome: an observational cohort study

Ann Intensive CarePublished Observational cohort study

Authors' conclusion

The transition phase represents a high-risk period in ARDS, with significant failure rates for NMBA weaning and PSV trials that may influence patient outcomes.

Study context

Population
Patients with moderate-to-severe ARDS requiring neuromuscular blockade (NMBA) continuous infusion within 72 h post-intubation
Participants
196 patients
Outcome
Rates of NMBA reintroduction and PSV failure during the transition phase (72 h following the first NMBA weaning attempt)
Methodological detailsbicentric
  • Bicentric

Main finding

As reported in the abstract

NMBA weaning failure

74

38%

Pressure support ventilation (PSV) initiated

147

75%

PSV failure rate

57%

Median time to PSV failure

9 h

6–24

Observational data: associations, not effects.

Secondary outcomes

Factors associated with NMBA reintroduction

OR (CI)P value
COVID-193.98 (1.95–8.41)P < 0.001
pH0.50 (0.30–0.79)P = 0.004
PaO2/FiO2 ratio0.92 (0.87–0.97)P = 0.007
High or low driving pressure (< 12 or ≥ 14 cmH2O) before first NMBA weaning attempt2.77 (1.16–7.14)P = 0.027

Factors associated with PSV failure

OR (CI)P value
Tidal volume1.28 (1.06–1.56)P = 0.012
Factors associated with PSV failure — High tidal volumes (> 8 mL/kg PBW) during PSV
43%

Outcomes associated with NMBA weaning failure and PSV failure · day 28

NMBA weaning failure associated with fewer ventilator-free days and increased mortality at day 28
PSV failure associated with fewer ventilator-free days

Original publication

Factors influencing the transition phase in acute respiratory distress syndrome: an observational cohort study. Ann Intensive Care. Published 26 May 2025. doi:10.1186/s13613-025-01484-6

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.